236 results on '"Mnejja, W."'
Search Results
2. Volumes tumoraux avant et après chimiothérapie : de nouveaux facteurs pronostiques dans les carcinomes nasopharyngés
3. État des lieux et perspectives thérapeutiques pour les carcinomes nasopharyngés localement évolués
4. Subclinical left ventricle impairment following breast cancer radiotherapy: Is there an association between segmental doses and segmental strain dysfunction?
5. Quel impact de la RCMI des carcinomes nasopharyngés sur les structures glandulaires ?
6. Apports et limites de la réirradiation conformationnelle avec modulation d’intensité des carcinomes nasopharyngés
7. TPF induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: Long term results of a Tunisian series
8. Therapeutic results of laryngeal preservation: a retrospective study
9. PO-1216 Quality of weight loss during chemo-radiotherapy of nasopharyngeal carcinoma
10. PO-1502 Prostate cancer in younger patients: Does it make a difference in oncological outcomes?
11. PO-1195 Should we delineate lacrimal gland during nasopharyngeal carcinoma radiotherapy?
12. PO-1215 Evaluation of Sexual Health in patients with Head and Neck Cancers
13. PO-1537 What factors may influence late urinary toxicities after radiation therapy of prostate cancers?
14. PO-1197 Dosimetric predictors of persistent xerostomia after IMRT for nasopharyngeal carcinoma
15. PO-1107 Interest and respect of the dosimeter wearing in the radiotherapy department
16. PO-1212 How did treatment affect body image in patients treated for Head and Neck Cancers?
17. PO-1210 Intensity modulated radiotherapy of nasopharyngeal carcinomas: locoregional failure patterns
18. 121P Acute skin toxicity after conservative surgery for breast cancer: Impact of radiotherapy fractionation
19. PO-1139 Hypofractionated radiotherapy for glioblastoma: therapeutic outcomes, toxicities and quality of life
20. PO-1563 What are the oesophagus dosimetric constraints during breast cancer hypofractionated radiotherapy?
21. PO-1562 Should we delineate brachial plexus in case of breast cancer hypofractionated radiotherapy?
22. PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
23. PO-1087 Tumour volume response to induction chemotherapy in nasopharyngeal carcinoma: TPF versus GP
24. 154P Screening of breast cancer: Clinical and biological profile of Tunisian women
25. PO-1466 Patients’ satisfaction during radiotherapy treatment
26. PO-1360 Are the practices of Radiation oncologists harmonious for hormone therapy in prostate cancer?
27. PO-0963 How to optimize prognosis prediction of nasopharyngeal carcinoma in the era of modern radiotherapy?
28. PO-1101 Optimal strategy to detect sub-clinical cardiac alterations in left sided breast cancer
29. PO-0999 Financial difficulties during chemo-radiotherapy for nasopharyngeal carcinoma: A prospective study
30. PO-1517 Which impact of the COVID-19 pandemic on residents training in radiotherapy?
31. PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer
32. PO-1194 Social life functioning evolution during chemoradiotherapy for nasopharyngeal carcinoma
33. PO-1103 Did the oncology resident need training on sexual health for oncology patients?
34. PO-1085 Sleep disorders in cancer patients: A missing symptom
35. PD-0086 Professional quality of life of Tunisian in training resident in oncology radiotherapy
36. PO-0978: Is there a correlation between radiation doses and heart segmental alterations at 6 months?
37. PO-1110: Bladder dose constraints for conformal radiotherapy in rectal cancer: adaptation to prescribed dose
38. PO-0847: Quality of life during chemo-radiotherapy for nasopharyngeal carcinoma: A prospective assessment
39. PO-1668: Can we use cascade deep learning for GTV delineation in adaptive radiotherapy for NPC?
40. PO-1655: Dosimetric impact of the anatomical pelvic organs variations during prostate cancer IMRT
41. 36P Molecular subtypes in Tunisian breast cancer
42. Irradiation ganglionnaire dans la prise en charge des cancers de la prostate : pratiques des radiothérapeutes tunisiens
43. Variation de la dose au niveau des structures neurologiques en fonction de la variation tumorale au cours de la radiothérapie conformationnelle avec modulation d’intensité des carcinomes du nasopharynx
44. Y a-t-il un intérêt à la replanification à mi-traitement au cours de la radiothérapie conformationnelle avec modulation d’intensité des carcinomes nasopharyngés ?
45. Peut-on réduire le volume après chimiothérapie d’induction des carcinomes nasopharyngés localement évolués ?
46. Radiothérapie conformationnelle des cancers du rectum : faut-il définir des contraintes spécifiques pour la vessie ?
47. Impact pronostique de la nouvelle classification TNM pour les cancers du nasopharynx
48. EP-1192 Hair loss during intensity modulated radiotherapy for nasopharyngeal carcinoma
49. EP-2196 Dosimetric impact of anatomical changes during IMRT for prostate cancer
50. PO-1117 Dosimetric effect of parotid glands geometric modifications during the IMRT for NPC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.